Abcam plc (ABCM) 是一家上市公司 屬於 醫療保健 板塊,經營於 生物科技 產業. 公司總部位於 Cambridge, 英国. 現任CEO為 Alan Thomas Hirzel BS,.
ABCM 擁有 IPO日期為 2020-10-22, 1,760 名全職員工, 在 NASDAQ Global Select, 市值為 $5.52B.
Abcam plc is a life science company headquartered in Cambridge, United Kingdom, specializing in the identification, development, and distribution of reagents and tools for scientific research, diagnostics, and drug discovery. The company's product portfolio includes primary and secondary antibodies, conjugated antibodies, immunoassays, proteins and peptides, edited cell lines, and complementary research tools such as cellular activity kits and cell signaling pathway tools. Abcam serves a diverse customer base encompassing academic institutions, research institutes, and commercial entities in the pharmaceutical, biotechnology, and diagnostics sectors. With established operations across the Americas, Europe, Asia Pacific, and other regions, the company distributes its products primarily through online channels. Founded in 1998, Abcam has established itself as a key supplier of essential scientific research materials globally.